Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1132035

	registered interest
	date	13/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Care Networks
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the requirements for primary care networks to engage with the local community will be.
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	uin	264406
	answer	answer is ministerial correction date of answer 18/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">Primary Care Networks (PCNs) are a new way for primary and community service organisations to work together. For PCNs to be successful they will need to work in partnership with local people and the communities they serve. Legal duties which currently apply to NHS service providers - including general practitioner practices - and commissioners around engagement and consultation will continue to be valid for PCNs.</ins></p></ins></p><p><del class="ministerial">NHS England and NHS Improvement, together with the National Institute for Health and Care Excellence, is developing a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England.</del></p><p><del class="ministerial">The commercial framework will support a single, transparent, robust and integrated pricing and market access process, and is being tested with and informed through consultation with stakeholders including the Association of the British Pharmaceutical Industry.</del></p><p><del class="ministerial">In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to outline progress on the development of the commercial framework. The consultation on the draft framework is anticipated to be launched in Quarter 3 2019 with consultation events to be held in Manchester and London, and implementation of the commercial framework is expected to follow.</del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 18/06/2019 16:34:05 question first ministerially corrected 19/06/2019 08:36:30 answering member 4455 label Biography information for Seema Kennedy previous answer version 123829 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	4249 label Biography information for Anne Marie Morris

1128442

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish the evidence (a) his Department and (b) the Department for International Trade holds on growing a market for prescribed medicinal cannabis.
	tabling member constituency	Hemel Hempstead
	tabling member printed	Sir Mike Penning
	uin	257706
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">The Department for International Trade and the Department of Health and Social Care are not specifically collecting data on the growth of the market for cannabis based products for medicinal use in the United Kingdom.</ins></p><p><ins class="ministerial">However, data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows growing numbers of import notifications for medicinal cannabis and the Home Office has received increased numbers of licence applications.</ins></p><p><ins class="ministerial">In addition, UK companies exporting these products and foreign companies looking to invest in the UK have full access to government support, where they have the necessary authorisations from the MHRA and Home Office and a relevant Export Licence.</ins></p></ins></p><p><del class="ministerial">An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</del></p><p><del class="ministerial"><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></del></p><p><del class="ministerial">This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</del></p><p><del class="ministerial">In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</del></p><p><del class="ministerial"><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:18:03 question first ministerially corrected 11/06/2019 11:31:21 answering member 4455 label Biography information for Seema Kennedy previous answer version 121340 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1528 label Biography information for Sir Mike Penning

1127949

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	5G: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what studies have been carried out to evaluate the effect of 5G on (a) pregnant women, (b) babies and (c) young children.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	256920
	answer	answer is ministerial correction date of answer 30/05/2019 answer text <p>A considerable amount of research has been carried out on exposure to radio waves over several decades, and evidence reviews have been prepared by scientific expert groups in the United Kingdom and around the world. Among the health topics investigated is whether adverse effects can occur in relation to reproduction and development.</p><p>Public Health England (PHE) has published a webpage about exposure to the radio waves from mobile phone base stations, including those for 5G networks, at the following link:</p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p>Based on the accumulated evidence and reviews, PHE advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that radio wave exposures below the ICNIRP guideline levels cause adverse health effects. This includes effects in relation to reproduction and development.</p><p>PHE has committed to keeping the emerging evidence under review and to preparing another comprehensive review when sufficient new evidence has accumulated.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 30/05/2019 10:39:58 answering member 4455 label Biography information for Seema Kennedy
	tabling member	252 label Biography information for Dr David Drew

1124675

	registered interest
	date	03/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people with HIV are (a) diagnosed and (b) receiving treatment.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	250669
	answer	answer is ministerial correction date of answer 09/05/2019 answer text <p>A range of approaches are in place to help diagnose people living with HIV as early as possible. The Government has mandated local authorities in England to commission comprehensive open access sexual health services, including free sexually transmitted infection testing and treatment. All parts of the country provide access to different HIV testing options such as HIV self- sampling services, or community HIV testing activities.</p><p> </p><p>The National Health Service continues to provide world class treatment and care for people living with HIV. In 2017, 92% people living with HIV infection in the United Kingdom were diagnosed, 98% of people diagnosed were receiving treatment and 97% of people receiving treatment were virally suppressed.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/05/2019 15:58:46 answering member 4455 label Biography information for Seema Kennedy
	tabling member	308 label Biography information for Mr Jim Cunningham

1126678

	registered interest
	date	14/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescriptions: Universal Credit
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timeframe is for NHS prescription forms to be amended to include tick boxes for universal credit.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	254153
	answer	answer is ministerial correction date of answer 20/05/2019 answer text <p>A revised version of the FP10 prescription form, featuring a dedicated tick-box for use by Universal Credit claimants who meet the criteria for free National Health Service prescriptions, recently received Ministerial clearance.</p><p> </p><p>Any change involves major system and software updates across the NHS to allow the re-designed form to be used and processed. The revised paper form is currently being prepared for testing, to ensure it is compatible with the scanners used by the NHS Business Services Authority.</p><p> </p><p>The revised form will be introduced at the earliest opportunity.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/05/2019 15:59:00 answering member 4455 label Biography information for Seema Kennedy
	tabling member	478 label Biography information for Lord Field of Birkenhead

1110984

	registered interest
	date	10/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Urinary Tract Infections: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 April 2019 to Question 237733, what representations he has received on the capability of NHS urinary trace infection screening tests to detect bacteria hidden in the bladder's lining.
	tabling member constituency	Tooting
	tabling member printed	Dr Rosena Allin-Khan
	uin	243537
	answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>A search of the Department’s Ministerial correspondence database has identified four items of correspondence received on the capability of National Health Service urinary tract infection (UTI) screening tests to detect bacteria in the bladder's lining during the past 12 months. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p>In November 2018 Public Health England published guidance on the diagnosis of UTIs. This guidance states that “no individual or combination (of symptoms or dipstick) are completely reliable in diagnosing UTI, thus severity of symptoms and safety-netting are important.”</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:22:09 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4573 label Biography information for Dr Rosena Allin-Khan

1109438

	registered interest
	date	03/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure that the serious shortage protocols safeguard individuals who suffer from a condition, such as epilepsy, in which any change in medication could pose a serious risk to their health.
	tabling member constituency	Ross, Skye and Lochaber
	tabling member printed	Ian Blackford
	uin	240571
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>A serious shortage protocol is an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective. Any protocol would only be introduced if clinicians with expertise in the relevant area think it is appropriate. Pharmacists still have to use their professional discretion as to whether supplying against the protocol rather than the prescription is appropriate, or whether the patient needs to be referred back to their prescriber.</p><p> </p><p>As the explanatory memorandum of the amending Statutory Instrument acknowledges, protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients. For example, those types of protocols would not be suitable for treatments for epilepsy or treatments requiring biological products where the medicines that are prescribed need to be prescribed by brand for clinical reasons. In these cases, patients would always be referred back to the prescriber for any decision about their treatment before any therapeutic or generic alternative is supplied.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:24:32 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4390 label Biography information for Ian Blackford

1129760

	registered interest
	date	04/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will place in the Library information on the number of people that have been diagnosed with early breast cancer in each Care Commissioning Group in England in the last year for which data is available.
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	uin	260034
	answer	answer is ministerial correction date of answer 12/06/2019 answer text <p>A table showing the number of people diagnosed with early breast cancer (stages one and two), and the total people diagnosed with breast cancer, in 2017 in each clinical commissioning group is attached. Data are available from the following link:</p><p><a href="http://www.ncin.org.uk/publications/survival_by_stage" target="_blank">http://www.ncin.org.uk/publications/survival_by_stage</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 12/06/2019 16:25:00 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name 260034 table formatted.docx title Breast cancer diagnoses by CCG 2017
	tabling member	4382 label Biography information for Daniel Zeichner

1124341

	registered interest
	date	01/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hepatitis: Primary Health Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve awareness of hepatitis C among primary care professionals.
	tabling member constituency	Worthing West
	tabling member printed	Sir Peter Bottomley
	uin	249817
	answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>A variety of initiatives are underway in England to improve hepatitis C awareness and case finding, re-engagement and linkage to care, especially in drug services, primary care, prisons and accident and emergency centres. In addition, NHS England is funding access to new hepatitis C treatments in accordance with guidance from the National Institute for Health and Care Excellence.</p><p> </p><p>Public Health England has developed and shared materials with a range of stakeholders, including the voluntary sector, to help raise awareness of hepatitis C infection and highlight the need for those at risk to seek testing and treatment. The resources and materials available comprise of posters, a quiz, social media videos and social banners in a variety of different languages; all of these resources are available online to download or order by healthcare professionals as well as the public themselves.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:57:09 answering member 4455 label Biography information for Seema Kennedy
	tabling member	117 label Biography information for Sir Peter Bottomley

1129388

	registered interest
	date	03/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Contraceptives
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to promote the uptake of long-acting reversible contraception methods.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	259467
	answer	answer is ministerial correction date of answer 06/06/2019 answer text <p>A wide range of contraceptive choices, including long-acting reversible contraception (LARC), are available free of charge in a range of primary and community venues and local authorities are mandated to provide reasonable access to all methods of contraception. The proportion of women attending sexual and reproductive health services who use LARC methods has been steadily rising over the last ten years. The Department will work with Public Health England to consider what more we can do to ensure that all women have access to the full range of contraception.</p><p><strong> </strong></p><p><strong> </strong></p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 06/06/2019 13:19:12 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson